Clinical Trials on Muscular Atrophy, Spinal, Type II in Belgium
Total 310 results
-
Hoffmann-La RocheAssociation Française contre les Myopathies (AFM), ParisCompletedSpinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type III Non AmbulantGermany, Italy, France, Belgium, Poland, Netherlands, United Kingdom
-
Novartis Gene TherapiesActive, not recruitingSMA | Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type I | Spinal Muscular Atrophy Type IIIUnited States, Belgium, France, Japan, United Kingdom, Italy, Taiwan, Australia, Canada
-
Institut de Myologie, FranceInstitut RocheCompletedType 2 Spinal Muscular Atrophy | Type 3 Spinal Muscular AtrophyBelgium, France, Germany
-
Scholar Rock, Inc.Active, not recruitingNeuromuscular Diseases | Neuromuscular Manifestations | Atrophy | Muscular Atrophy | Spinal Muscular Atrophy | Muscular Atrophy, Spinal | Spinal Muscular Atrophy Type 3 | SMA | Anti-myostatin | Spinal Muscular Atrophy Type IIUnited States, Spain, Belgium, Germany, Netherlands, Poland, Italy, France, United Kingdom
-
Centre Hospitalier Régional de la CitadelleCompletedSafety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3 (EMOTAS)Spinal Muscular Atrophy Type 3Belgium
-
Centre Hospitalier Universitaire de LiegeQueen Fabiola Children's University Hospital; Erasme University Hospital; Centre... and other collaboratorsActive, not recruiting
-
Centre Hospitalier Régional de la CitadelleRoche Pharma AG; Biogen; AveXis, Inc.; Association Belge contre les Maladies neuro...CompletedSpinal Muscular AtrophyBelgium
-
Scholar Rock, Inc.Active, not recruitingNeuromuscular Diseases | Neuromuscular Manifestations | Atrophy | Muscular Atrophy | Spinal Muscular Atrophy | Muscular Atrophy, Spinal | Spinal Muscular Atrophy Type 3 | SMA | Spinal Muscular Atrophy Type 2 | Anti-myostatinUnited States, Germany, Belgium, Spain, United Kingdom, Netherlands, France, Italy, Poland
-
Hoffmann-La RocheRecruitingMuscular Atrophy, SpinalGermany, United States, Belgium, Italy
-
Novartis Gene TherapiesCompletedSMAFrance, United Kingdom, Italy, Belgium
-
Novartis PharmaceuticalsCompletedSpinal Muscular AtrophyBelgium, Germany, Italy, Russian Federation, Poland, Bulgaria, Denmark
-
Hoffmann-La RocheRecruitingSpinal Muscular Atrophy (SMA)Belgium, United States, Croatia, Japan, Netherlands, Spain, Canada, Poland, United Kingdom, Portugal, Italy, Australia
-
Hoffmann-La RocheActive, not recruitingMuscular Atrophy, SpinalUnited States, Belgium, Brazil, Russian Federation, Australia, Taiwan, Poland
-
Novartis PharmaceuticalsRecruitingSpinal Muscular Atrophy (SMA)Spain, Canada, Taiwan, Belgium, Malaysia, China, Japan, Italy, Singapore, United Kingdom, France, Australia, Thailand, Denmark, United States
-
Hoffmann-La RocheActive, not recruitingSpinal Muscular AtrophyBelgium, United States, United Kingdom, France, Poland, Italy, Switzerland, Netherlands, Germany
-
Novartis Gene TherapiesPRA Health SciencesCompletedSpinal Muscular AtrophyUnited States, United Kingdom, Australia, Belgium, Canada, Japan
-
Hoffmann-La RocheCompletedMuscular Atrophy, SpinalBelgium, United Kingdom, Germany, France, Italy, Netherlands, Poland
-
NMD Pharma A/SRecruitingSpinal Muscular AtrophyUnited States, Spain, Belgium, Denmark, Germany, Netherlands, Italy, Canada
-
Hoffmann-La RocheCompletedMuscular Atrophy, SpinalBelgium, United States, China, Spain, Japan, Canada, France, Poland, Brazil, Croatia, Italy, Russian Federation, Turkey, Germany, Serbia, United Kingdom
-
Hoffmann-La RocheCompletedMuscular Atrophy, SpinalBelgium, United States, China, Spain, Japan, France, Brazil, Croatia, Italy, Russian Federation, Saudi Arabia, Serbia, Switzerland, Turkey, Ukraine, Poland
-
BiogenCompletedSpinal Muscular AtrophyUnited States, Spain, Germany, United Kingdom, Australia, Japan, Canada, Belgium, France, Hong Kong, Italy, Korea, Republic of, Sweden, Turkey
-
BiogenTerminatedSpinal Muscular AtrophyKorea, Republic of, United States, Spain, Canada, Germany, Australia, Japan, Sweden, Belgium, France, Italy, Turkey, United Kingdom
-
Novartis PharmaceuticalsCompletedSpinal Muscular AtrophyTaiwan, Belgium, Canada, United States, Australia, France, Italy, Portugal, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingSpinal Muscular AtrophyJapan, Belgium, Spain, Canada, United States, Australia, Italy, France, Netherlands
-
Biohaven Pharmaceuticals, Inc.Active, not recruitingNeuromuscular Diseases | Spinal Muscular Atrophy | SMAUnited States, Netherlands, United Kingdom, Spain, Czechia, Belgium, Germany, Italy, Poland
-
BiogenRecruitingHealthy Volunteer | Muscular Atrophy, SpinalKorea, Republic of, Germany, Belgium, Netherlands, France, Italy, Poland, Canada, United Kingdom, Israel
-
Hasselt UniversityJessa Hospital; Sint-Trudo Hospital; Sint-Franciscus ZiekenhuisSuspendedExtreme Lateral Interbody FusionFUSION (XLIF) Versus Posterior Lumbar Interbody Fusion (PLIF) (XLIF)Atrophy | Muscle Damage | Degenerative Diseases, Spinal CordBelgium
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Brugmann University HospitalWithdrawn
-
Brugmann University HospitalCompleted
-
Murielle SurquinCompleted
-
ArtialisRecruiting
-
Universitaire Ziekenhuizen KU LeuvenKU Leuven; Research Foundation FlandersRecruiting
-
Universiteit AntwerpenUniversitaire Ziekenhuizen KU Leuven; Jagiellonian University; Catholic University... and other collaboratorsRecruiting
-
Universitaire Ziekenhuizen KU LeuvenCompletedSpinal Dysraphism | Chiari Malformation Type 2 | Fetal AnomalyBelgium
-
Universitaire Ziekenhuizen KU LeuvenKU Leuven; VISTA-Life; Nestlé Health Science BelgiumRecruiting
-
Murielle SurquinCompleted
-
Frank VandenabeeleJessa HospitalRecruiting
-
Vrije Universiteit BrusselCompletedStroke | SarcopeniaBelgium
-
Cliniques universitaires Saint-Luc- Université...CompletedAlterations of Muscle Secretome Associated With Muscle Atrophy Caused by Glucocorticoids (MYOSECRET)Cushing SyndromeBelgium
-
Brugmann University HospitalCompletedSarcopenia | Old Age; Debility | SensitivityBelgium
-
Hasselt UniversityJessa HospitalCompletedCritical Illness | Cachexia | Muscle Atrophy | Muscle Loss | Muscle WastingBelgium
-
Universitaire Ziekenhuizen KU LeuvenRecruitingAging | Overweight and Obesity | Sarcopenic Obesity | Bariatric SurgeryBelgium
-
Vrije Universiteit BrusselUniversitair Ziekenhuis Brussel; Revalidatieziekenhuis InkendaaINot yet recruitingStroke | COVID-19 | Muscle Weakness | Frailty | SarcopeniaBelgium
-
Universitaire Ziekenhuizen KU LeuvenCompletedSarcopenia | OsteoporosisBelgium
-
University Hospital, AntwerpNot yet recruitingMalnutrition | Cirrhosis | SarcopeniaBelgium
-
PfizerCompletedDiabetes Mellitus, Type IIBelgium
-
University Hospital, GasthuisbergKU Leuven; Kom Op Tegen Kanker; Research Foundation FlandersRecruitingPostoperative Complications | Muscle Weakness | Esophageal Cancer | Sarcopenia | Nutrition Aspect of Cancer | Jejunostomy; ComplicationsBelgium
-
Brugmann University HospitalCompleted
-
KU LeuvenCompletedKetosis | Protein Intake | Muscle Wasting | Caloric RestrictionBelgium